Biodegradable Drug Eluting Stents Market By material ( Metallic Alloy Stents, Polymeric Stents),  Application (Coronary Artery Disease, Peripheral Artery Disease), end-user,(Hospitals ardiac Centers) Geography (North America, Latin America, Europe, Asia Pacific and Middle East and Africa)

 

Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

Biodegradable Drug Eluting Stents Market size was valued at USD x billion in 2021, growing at a CAGR of 5.3% from 2023-28. Drug-eluting stents are peripheral or coronary stents placed into narrowed peripheral or coronary arteries that slowly release the drug to block cell proliferation. Generally, these devices are made up of metal and remain permanently or removed through further surgery. Metal stents present drawbacks such as the predisposition to late stent thrombosis, impairment of imaging with multislice CT, hindrance of surgical revascularization. Biodegradable drug-eluting stents are made up of material that dissolves or absorbed in the body, these are temporary, and no need for further surgery to removal of the stent. These are also called as bioresorbable stents or naturally- dissolving stents. In October 2015, Boston Scientific Corporation received U.S. Food and Drug Administration (FDA) approval for the synergy bioabsorbable Polymer Drug-Eluting Stent System (BP-DES) for the treatment of coronary artery disease. Risk of complications in use and lower awareness about biodegradable stents among healthcare professionals in developing and developed regions are expected to hamper the growth of Biodegradable Drug Eluting Stents Market over the forecast period.

Global Biodegradable Drug Eluting Stents Market Summary

Study Period

2023-29

Base Year

2022

CAGR

5.3%

Largest Market

North America

Fastest Growing Market

Asia Pacific
Biodegradable Drug Eluting Stents Market Dynamics

Biodegradable Drug growth is driven by growing prevalence of coronary artery diseases, increased geriatric population who are more prone to heart diseases. According to World Health Organization (WHO), cardiovascular diseases are a primary cause of deaths globally, an estimated 17.7 Mn people died from cardiovascular diseases in 2015, representing 31% of all global deaths. Of these deaths, an estimated 7.4 Mn were due to coronary heart disease and 6.7 million were due to heart stroke. Furthermore, biodegradable drug-eluting stents have various advantages over the traditional metal stents such as no need of further surgery to remove stent, quick restoration of blood flow and faster healing process which are expected to boost the biodegradable drug eluting stents market.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Global Biodegradable Drug Eluting Stents Market Segmentation

Type of Material
  • Metallic Alloy Stents
  • Polymeric Stents
Application
  • Coronary Artery Disease
  • Peripheral Artery Disease
End-user
  • Hospitals
  • Cardiac Centers
Geography
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa)

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

  1. Executive summary
  2. Global Biodegradable Drug Eluting Stents Market Introduction
    • Global Biodegradable Drug Eluting Stents Market? Taxonomy
    • Global Biodegradable Drug Eluting Stents Market?Definitions
      • Material Type
      • Application
  1. Global Biodegradable Drug Eluting Stents Market Dynamics
    • Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
    • Global Biodegradable Drug Eluting Stents Market Dynamics ? Factors Impact Analysis
    • Global Biodegradable Drug Eluting Stents Market? Recent Market Introductions
  2. Global Biodegradable Drug Eluting Stents Market Analysis, 2013 - 2017 and Forecast, 2018 ? 2024
    • Market Analysis, 2013 ? 2017 and Forecast, 2018 ? 2024 (Revenue, USD Mn)
    • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Market Oppurtunity Analysis
  3. Global Biodegradable Drug Eluting Stents Market Forecast, By Material Type, 2013 - 2017 and Forecast, 2018 - 2024
    • Metallic Alloy Stents
      • Market Analysis, 2013 ? 2017 and Forecast, 2018 ? 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Polymeric Stents
      • Market Analysis, 2013 ? 2017 and Forecast, 2018 ? 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Biodegradable Drug Eluting Stents Market Forecast, By Application, 2013 - 2017 and Forecast, 2018 - 2024
    • Coronary Artery Disease
      • Market Analysis, 2013 ? 2017 and Forecast, 2018 ? 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Peripheral Artery Disease
      • Market Analysis, 2013 ? 2017 and Forecast, 2018 ? 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Biodegradable Drug Eluting Stents Market Forecast, By End User, 2013 - 2017 and Forecast, 2018 - 2024
    • Hospitals
      • Market Analysis, 2013 ? 2017 and Forecast, 2018 ? 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Cardiac Centers
      • Market Analysis, 2013 ? 2017 and Forecast, 2018 ? 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Biodegradable Drug Eluting Stents Market Forecast, By Region, 2013 - 2017 and Forecast, 2018 - 2024
    • North America
      • Market Analysis, 2013 ? 2017 and Forecast, 2018 ? 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Europe
      • Market Analysis, 2013 ? 2017 and Forecast, 2018 ? 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Asia-Pacific
      • Market Analysis, 2013 ? 2017 and Forecast, 2018 ? 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Latin America
      • Market Analysis, 2013 ? 2017 and Forecast, 2018 ? 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Middle East and Africa
      • Market Analysis, 2013 ? 2017 and Forecast, 2018 ? 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Global Biodegradable Drug Eluting Stents Market- Opportunity Analysis Index - By Material Type, By Application, By End User, and Region, 2018 ? 2024
  2. North America Biodegradable Drug Eluting Stents Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024
    • Material Type Analysis (2013 ? 2017) and Forecast (2018 ? 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Metallic Alloy Stents
      • Polymeric Stents
    • Application Analysis (2013 ? 2017) and Forecast (2018 ? 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Coronary Artery Disease
      • Peripheral Artery Disease
    • End User Analysis (2013 ? 2017) and Forecast (2018 ? 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Cardiac Centers
    • Country Analysis (2013 ? 2017) and Forecast (2018 ? 2024) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • S.
      • Canada
    • North America Biodegradable Drug Eluting Stents Market- Opportunity Analysis Index - By Material Type, By Application, By End User, and Country, 2018 ? 2024
    • North America Biodegradable Drug Eluting Stents Market Dynamics ? Trends
  3. Europe Biodegradable Drug Eluting Stents Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024
    • Material Type Analysis (2013 ? 2017) and Forecast (2018 ? 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Metallic Alloy Stents
      • Polymeric Stents
    • Application Analysis (2013 ? 2017) and Forecast (2018 ? 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Coronary Artery Disease
      • Peripheral Artery Disease
    • End User Analysis (2013 ? 2017) and Forecast (2018 ? 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Cardiac Centers
    • Country Analysis (2013 ? 2017) and Forecast (2018 ? 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Germany
      • UK
      • France
      • Spain
      • Italy
      • Russia
      • Poland
      • Rest of Europe
    • Europe Biodegradable Drug Eluting Stents Market- Opportunity Analysis Index - By Material Type, By Application, By Harvesting, By End User, and Country, 2018 ? 2024
    • Europe Biodegradable Drug Eluting Stents Market Dynamics ? Trends
  4. Asia-Pacific Biodegradable Drug Eluting Stents Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024
    • Material Type Analysis (2013 ? 2017) and Forecast (2018 ? 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Metallic Alloy Stents
      • Polymeric Stents
    • Application Analysis (2013 ? 2017) and Forecast (2018 ? 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Coronary Artery Disease
      • Peripheral Artery Disease
    • End User Analysis (2013 ? 2017) and Forecast (2018 ? 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Cardiac Centers
    • Country Analysis (2013 ? 2017) and Forecast (2018 ? 2024) by Revenue (USD Mn),
  5. Y-o-Y Growth (%), and Market Share (%)
    • Japan
    • China
    • India
    • ASEAN
    • Australia & New Zealand
    • Rest of Asia-Pacific
  • Asia-Pacific Biodegradable Drug Eluting Stents Market- Opportunity Analysis Index - By Material Type, By Application, By Harvesting, By End User, and Country, 2018 ? 2024
  • Asia-Pacific Biodegradable Drug Eluting Stents Market Dynamics ? Trends
  1. Latin America Biodegradable Drug Eluting Stents Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024
    • Material Type Analysis (2013 ? 2017) and Forecast (2018 ? 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Metallic Alloy Stents
      • Polymeric Stents
    • Application Analysis (2013 ? 2017) and Forecast (2018 ? 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Coronary Artery Disease
      • Peripheral Artery Disease
    • End User Analysis (2013 ? 2017) and Forecast (2018 ? 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Cardiac Centers
    • Country Analysis (2013 ? 2017) and Forecast (2018 ? 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Brazil
      • Mexico
      • Argentina
      • Venezuela
      • Rest of Latin America
    • Latin America Biodegradable Drug Eluting Stents Market- Opportunity Analysis Index - By Material Type, By Application, By Harvesting, End User, and Country, 2018 ? 2024
    • Latin America Biodegradable Drug Eluting Stents Market Dynamics ? Trends
  2. Middle East & Africa Biodegradable Drug Eluting Stents Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024
    • Material Type Analysis (2013 ? 2017) and Forecast (2018 ? 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Metallic Alloy Stents
      • Polymeric Stents
    • Application Analysis (2013 ? 2017) and Forecast (2018 ? 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Coronary Artery Disease
      • Peripheral Artery Disease
    • End User Analysis (2013 ? 2017) and Forecast (2018 ? 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Cardiac Centers
    • Country Analysis (2013 ? 2017) and Forecast (2018 ? 2024) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Gulf Cooperation Council (GCC) Countries
      • Israel
      • South Africa
      • Rest of MEA
    • MEA Biodegradable Drug Eluting Stents Market- Opportunity Analysis Index - By Material Type, By Application, By Harvesting, By End User, and Country, 2018 ? 2024
    • MEA Biodegradable Drug Eluting Stents Market Dynamics ? Trends
  3. Competition Landscape
    • Strategic Dashboard of Top Market Players
    • Company Profiles (Introduction, Financial Analysis, Drug & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
      • Biosensors International Group (Singapore)
      • Abbott Laboratories (U.S)
      • Medtronic (U.S.)
      • Braun Holding GmbH & Co. KG (B.Braun Melsungen) (Germany)
      • Boston Scientific Corporation (U.S.)
      • Terumo Corporation (Japan)
  4. Research Methodology
  5. Key Assumptions and Acronyms
  • Biosensors International Group (Singapore)
  • Abbott Laboratories (U.S)
  • Medtronic (U.S.)
  • B. Braun Holding GmbH & Co. KG (B.Braun Melsungen) (Germany)
  • Boston Scientific Corporation (U.S.)
  • Terumo Corporation (Japan)